Therefore, our study clearly suggests that in CLL, non-malignant T cells appear to be an important effector population involved in the p27Kip1 and cyclin D2 genetic determination of the clinical outcomes of CLL. The gene discussed is CCND2; the disease is B-cell chronic lymphocytic leukemia.